Centene (NYSE:CNC) Shares Acquired Rep. Tim Moore

Key Points

• Representative Tim Moore recently purchased shares of Centene Corporation (NYSE:CNC), spending between $1,001 and $15,000 on July 22nd.
• Centene reported a loss of ($0.16) earnings per share for the last quarter, missing analysts' estimates and despite a revenue increase of 22.4% compared to the previous year.
• Recent analyst downgrades have seen Centene's price targets significantly reduced, with Mizuho and Wells Fargo lowering theirs from $71.00 to $40.00 and $72.00 to $30.00 respectively.

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation NYSE: CNC. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in Centene stock on July 22nd.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/18/2025.

Centene Price Performance

Centene stock traded up $0.32 during trading hours on Friday, reaching $25.58. 11,416,944 shares of the stock were exchanged, compared to its average volume of 8,368,974. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $80.59. The company has a market cap of $12.56 billion, a P/E ratio of 6.33, a price-to-earnings-growth ratio of 1.03 and a beta of 0.40. The stock has a 50 day moving average of $40.30 and a two-hundred day moving average of $53.31.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.39). The firm had revenue of $48.74 billion during the quarter, compared to the consensus estimate of $44.71 billion. Centene had a net margin of 1.15% and a return on equity of 9.57%. The business's revenue was up 22.4% compared to the same quarter last year. During the same period last year, the business earned $2.42 earnings per share. Equities analysts expect that Centene Corporation will post 6.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Mizuho cut their price target on shares of Centene from $71.00 to $40.00 and set a "neutral" rating on the stock in a research report on Friday, July 11th. Barclays cut their target price on Centene from $65.00 to $45.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 2nd. UBS Group dropped their price target on Centene from $45.00 to $31.00 and set a "neutral" rating on the stock in a research note on Monday, July 28th. Jefferies Financial Group reduced their price objective on shares of Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research report on Tuesday, April 29th. Finally, Oppenheimer dropped their target price on shares of Centene from $51.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $42.20.

Insider Activity

In other Centene news, Director Theodore R. Samuels II acquired 9,000 shares of the business's stock in a transaction on Monday, July 28th. The shares were acquired at an average price of $27.62 per share, with a total value of $248,580.00. Following the completion of the transaction, the director owned 32,000 shares in the company, valued at approximately $883,840. This trade represents a 39.13% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.36% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Pinney & Scofield Inc. purchased a new stake in Centene in the 4th quarter valued at $25,000. Ameriflex Group Inc. purchased a new stake in shares of Centene in the fourth quarter valued at about $26,000. Quarry LP bought a new stake in Centene in the 1st quarter worth about $26,000. Studio Investment Management LLC purchased a new stake in Centene in the 4th quarter valued at about $32,000. Finally, Golden State Wealth Management LLC lifted its position in shares of Centene by 203.1% during the 1st quarter. Golden State Wealth Management LLC now owns 579 shares of the company's stock worth $35,000 after buying an additional 388 shares in the last quarter. Institutional investors own 93.63% of the company's stock.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.